Cancer drug: SC allows Cipla to withdraw appeal against Roche
The Supreme Court on Friday allowed domestic drug manufacturer Cipla, which recently arrived at a settlement with Swiss pharma major Roche over a lung cancer drug, to withdraw its petition on the patent row.
Jun 16, 2017, 15:18 PM ISTCipla infringing Roche's patent in lung cancer drug: HC
In a setback to Cipla, the Delhi High Court on Friday held that the Indian drug major was infringing Swiss pharmaceutical company Hoffman-La Roche's patent in lung cancer drug erlotinib hydrochloride, sold under the name of Tarceva.
Nov 28, 2015, 00:22 AM IST